This chapter discusses whether foreign investors, specifically pharmaceutical companies, could challenge India …'s regulatory measures that impact their patents under India's BITs. More specifically, the paper will focus on whether regulatory … expropriation under India's bilateral investment treaties (BITs). The discussion in the chapter shows that pharmaceutical patents …

India has charted its own intellectual property (IP) path over the last 35 years, attempting to foster the growth of a … international IP regime. Multinational companies (MNCs) have responded to India's movement towards compliance with WTO intellectual … the patenting and commercialization of new pharmaceutical products in India, waiting to see how Indian courts and patent …